Skip to main content

Publisher: Elsevier

Volume 248, Number 1, 1 February 2001

Introduction: bispecific antibodies
pp. 1-6(6)
Authors: Segal, D.M.; Weiner, G.J.; Weiner, L.M.

Favourites:
ADD

Bispecific human IgG by design
pp. 7-15(9)
Author: Carter, P.

Favourites:
ADD

Selection of cell binding and internalizing epidermal growth factor receptor antibodies from a phage display library
pp. 17-30(14)
Authors: Heitner, T.; Moor, A.; Garrison, J.L.; Marks, C.; Hasan, T.; Marks, J.D.

Favourites:
ADD

Ribosome display and affinity maturation: from antibodies to single V-domains and steps towards cancer therapeutics
pp. 31-45(15)
Authors: Irving, R.A.; Coia, G.; Roberts, A.; Nuttall, S.D.; Hudson, P.J.

Favourites:
ADD

Design and application of diabodies, triabodies and tetrabodies for cancer targeting
pp. 47-66(20)
Authors: Todorovska, A.; Roovers, R.C.; Dolezal, O.; Kortt, A.A.; Hoogenboom, H.R.; Hudson, P.J.

Favourites:
ADD

Functional expression of chimeric receptor genes in human T cells
pp. 67-76(10)
Authors: Eshhar, Z.; Waks, T.; Bendavid, A.; Schindler, D.G.

Favourites:
ADD

Development and applications of surface-linked single chain antibodies against T-cell antigens
pp. 77-90(14)
Authors: Griffin1, M.D.; Holman, P.O.; Tang, Q.; Ashourian, N.; Korthauer2, U.; Kranz, D.M.; Bluestone, J.A.

Favourites:
ADD

Antibody-cytokine fusion proteins for the therapy of cancer
pp. 91-101(11)
Authors: Penichet, M.L.; Morrison, S.L.

Favourites:
ADD

Mechanisms of G-CSF- or GM-CSF-stimulated tumor cell killing by Fc receptor-directed bispecific antibodies
pp. 103-111(9)
Authors: Stockmeyer, B.; Elsasser, D.; dechant, M.; Repp, R.; Gramatzki, M.; Glennie, M.J.; van de Winkel, J.G.J.; Valerius, T.

Favourites:
ADD

Bispecific antibody-mediated destruction of Hodgkin's lymphoma cells
pp. 113-123(11)
Authors: Sundarapandiyan, K.; Keler, T.; Behnke, D.; Engert, A.; Barth, S.; Matthey, B.; deo, Y.M.; Graziano, R.F.

Favourites:
ADD

A bispecific dsDNAxmonoclonal antibody construct for clearance of anti-dsDNA IgG in systemic lupus erythematosus
pp. 125-138(14)
Authors: Lindorfer, M.A.; Schuman, T.A.; Craig, M.L.; Martin, E.N.; Taylor, R.P.

Favourites:
ADD

CD40 ligation for immunotherapy of solid tumours
pp. 139-147(9)
Authors: Todryk, S.M.; Tutt, A.L.; Green, M.H.A.; Smallwood, J.A.; Halanek, N.; Dalgleish, A.G.; Glennie, M.J.

Favourites:
ADD

Pharmacokinetic-pharmacodynamic relationships of the bispecific antibody MDX-H210 when administered in combination with interferon gamma: a multiple-dose phase-I study in patients with advanced cancer which overexpresses HER-2/neu
pp. 149-165(17)
Authors: Lewis, L.D.; Cole, B.F.; Wallace, P.K.; Fisher, J.L.; Waugh, M.; Guyre, P.M.; Fanger, M.W.; Curnow, R.T.; Kaufman, P.A.; Ernstoff, M.S.

Favourites:
ADD

Bispecific antibody-targeted phagocytosis of HER-2/neu expressing tumor cells by myeloid cells activated in vivo
pp. 167-182(16)
Authors: Wallace, P.K.; Kaufman, P.A.; Lewis, L.D.; Keler, T.; Givan, A.L.; Fisher, J.L.; Waugh, M.G.; Wahner, A.E.; Guyre, P.M.; Fanger, M.W.; Ernstoff, M.S.

Favourites:
ADD

Exogenous antigen targeted to FcRI on myeloid cells is presented in association with MHC class I
pp. 183-194(12)
Authors: Wallace, P.K.; Tsang, K.Y.; Goldstein, J.; Correale, P.; Jarry, T.M.; Schlom, J.; Guyre, P.M.; Ernstoff, M.S.; Fanger, M.W.

Favourites:
ADD

Contents of Volume 248
pp. 195-195(1)

Favourites:
ADD

Guide for Authors
pp. 197-200(4)

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more